New ventures: Carigent enters drug delivery space with Yale nanoparticle technology Jan. 10, 2008 By Jennifer Boggs
Inspiration Teams with Celtic in $35M Hemophilia Deal Jan. 10, 2008 By Trista Morrison While ramping up to begin clinical trials with its recombinant Factor IX product for hemophilia B, Inspiration Biopharmaceuticals Inc. entered a $35 million collaboration with Celtic Pharmaceutical Holdings LP. (BioWorld Today)Read More
RSS